Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension

Clinical Pharmacology and Therapeutics

Volumn 64, Issue 1, 1998, Pages 96-105

  Lafleche, Anne ^b   Gautier, Sylvie ^b   Topouchian, Jirar ^b   Wilmet, Catherine S ^b   Girerd, Xavier ^b   Safar, Michel E ^a   Benetos, Athanase ^b  

^a HÔPITAL BROUSSAIS   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRENDIPINE; NORADRENALIN; PLACEBO; RAMIPRIL;

ABDOMINAL AORTA; ADULT; AGED; ARTICLE; CAROTID ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; FEMORAL ARTERY; HUMAN; HYPERTENSION; MALE; MUSCLE MASS; MUSCLE STIFFNESS; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; AORTA, ABDOMINAL; ARTERIES; BLOOD PRESSURE; CAROTID ARTERIES; COMPLIANCE; DOUBLE-BLIND METHOD; FEMALE; HEART; HORMONES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRENDIPINE; RADIAL ARTERY; RAMIPRIL;

EID: 0031845520     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90027-3     Document Type: Article

References (33)

1. Safar ME, London GM. The arterial system in human hypertension. In: Swales JD, editor. Textbook of hypertension. London: Blackwell Scientific; 1994. p. 85-102.
2. Nichols WW, O'Rourke MF. McDonald's blood flow in arteries: theoretical, experimental and clinical principles. 4th ed. London:Arnold E; 1998. p. 54-113, 201-22, 284-92, 347-401.
3. Hayoz D, Rutschmann B, Perret F, Niedelberger M, Tardy Y, Mooser V, et al. Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 1992;10:l-6.
4. Kool MJ, Lustermans FA, Breed JG, Struijker Boudier HA, Hoeks AP, Reneman RS, et al. The influence of perindopril and the diuretic combination amiloride plus hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J Hypertens 1995;13:839-48.
5. Laurent S, Caviezel B, Beck L, Girerd X, Billaud E, Boutouyrie P, et al. Carotid artery distensibility and dis-tending pressure in hypertensive humans Hypertension 1994;23(pt 2):878-83.
6. Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992;86:1909-18.
7. Girerd X, Mourad JJ, Copie X, Moulin C, Acar C, Safar M, et al. Non-invasive detection of an increased vascular mass in untreated hypertensive patients. Am J Hypertens 1994;7:1076-84.
8. Isnard RN, Pannier BM, Laurent St, London GM, Diebold B, Safar ME. Pulsatile diameter and elastic mod-ulus of the aortic arch in ssential hypertension: a noninvasive study. J Am Coll Cardiol 1989;13:399-405.
9. Imura T, Yamamoto K, Kanamori K, Mikami T, Yasuda H. Noninvasive ultrasonic measurement of the elastic properties of the human abdominal aorta. Cardiovasc Res 1986;20:208-14.
10. Girerd X, Mourad JJ, Acar C, Heudes D, Chiche S, Bruneval P, et al. Noninvasive measurement of medium sized artery intima-media thickness in humans: in vitro validation. J Vase Res 1994;31:114-20.
11. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end-stage renal disease: comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994;90:2786-96.
12. Safar ME, Girerd X, Laurent S. Structural changes of large conduit arteries in hypertension. J Hypertens 1996;14:545-55.
13. Safar M, Frohlich E. The arterial system in hypertension. Hypertension 1995;26:10-4.
14. Kaplan NM, editor. Clinical hypertension. 4th ed. Baltimore: Williams and Wilkins; 1986. p. 180-272.
15. Lièvre M, Guéret P, Gayet C, Roudaut R, Haugh MC, Delair S, Boissel JP, et al. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. Hypertension 1995;25:92-7.
16. Dahlof B, Pennert K, Hansson L. Regression of left ventricular hypertrophy: a meta-analysis. Clin Exp Hypertens 1992;14:173-80.
17. Beil AH, Schmieder RE, Messerli FH. Salt intake, blood pressure, and cardiovascular structure. Cardiovasc Drugs Ther 1994;8:425-32.
18. Levy BI, Michel JL, Salzmann JL, Azizi M, Poitevin F, Safar ME, et al. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res 1988;63:227-9.
19. Levy BI, Michel JL, Salzmann JL, Poitevin F, Devissaguet M, Scalbert E, et al. Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats. Am J Cardiol 1993;71:8E-16E.
20. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Lévy BI, Safar ME, et al. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 1994;23:74-82.
21. Girerd X, Giannattasio C, Moulin C, Safar M, Mancia G, Laurent S. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after longterm antihypertensive treatment in elderly patients. J Am Coll Cardiol 1998;31:1064-73.
22. De Luca N, Savonitto S, Ricciardelli B, Marchegiano R, Lamenza F, Lembo G, et al. Effects of the single and repeated administration of benazepril on systemic and forearm circulation and cardiac function in hypertensive patients. Cardiovasc Drugs Ther 1993;7:211-6.
23. Bellissant E, Thuillez C, Richer C, Pussard E, Giudicelli JF. Non-invasive assessment of regional arteriolar and arterial dilating properties of lisinopril in healthy volunteers. J Cardiovasc Pharmacol 1994;24:500-6.
24. De Luca N, Rosiello G, Lamenza F, Ricciardelli B, Marchegiano R, Volpe M, et al. Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolapril. Am J Cardiol 1992;70:52D-9D.
25. Barenbrock M, Spieker C, Hoeks APG, Zidek W, Rahn KH. Effect of lisinopril and metoprolol on arterial distensibility. Hypertension 1994;24(suppl 1): 161-3-7.
26. Chen CH, Ting CT, Lin SJ, Hsu TL, Yin FCP, Sui CO, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 1995;25. 1034-41.
27. Schartl M, Bocksch WG, Dreysse S, Beckmann S, Franke O, Uunten U. Remodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensive patients. J Hypertens 1994;12(suppl 4):S37-42.
28. De Cesaris R, Ranieri G, Filitti V, Andirani A, Bonfantino MV. Forearm arterial distensibility in patients with hypertension: comparative effects of long-term ACE inhibition and β-blocking agents. Pharmacodynamics and drug action. Clin Pharmacol Ther 1993;53:360-7.
29. Ting CT, Yang TM, Chen JW, Chang MS, Yin FCR Arterial hemodynamics in human hypertension: effects of angiotensin converting enzyme inhibition. Hypertension 1993;22:839-46.
30. Van Bortel LM, Kool MJ, Struijker Boudier HA. Effects of antihypertensive agents on local arterial distensibility and compliance. Hypertension 1995;26:531-4.
31. London GM, Safar ME, Levy BI. Arterial compliance and effect of calcium antagonists. In: Murray Epstein, editor. Calcium antagonists in clinical medicine. Philadelphia: Hanley and Belfus; 1992. p. 89-103.
32. Watson PA. Mechanical activation of signaling pathways in the cardiovascular system. Trends Cardiovasc Med 1996;6:73-9.
33. Bardy N, Merval R, Benessiano J, Samuel JL, Tedgui A. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta: evidence for a pressure-induced tissue reninangiotensin system. Circ Res 1996;79:70-8.